Abstract | AIMS:
C-type natriuretic peptide (CNP) is a local regulator of vascular tone and remodeling in many vascular beds. However, the role of CNP in modulating pulmonary arterial hypertensive and vascular remodeling responses is unclear. The purpose of this study was to determine if CNP is capable of preventing the development of pulmonary hypertension (PH). MAIN METHODS: KEY FINDINGS: SIGNIFICANCE:
|
Authors | Brian Casserly, Jeffrey M Mazer, Alexander Vang, Elizabeth O Harrington, James R Klinger, Sharon Rounds, Gaurav Choudhary |
Journal | Life sciences
(Life Sci)
Vol. 89
Issue 13-14
Pg. 460-6
(Sep 26 2011)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 21820448
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Published by Elsevier Inc. |
Chemical References |
- Indoles
- Natriuretic Agents
- Protein Kinase Inhibitors
- Pyrroles
- Natriuretic Peptide, C-Type
- Semaxinib
- Receptors, Vascular Endothelial Growth Factor
|
Topics |
- Animals
- Hemodynamics
(drug effects)
- Hypertension, Pulmonary
(chemically induced, metabolism, pathology, prevention & control)
- Hypertrophy, Right Ventricular
(metabolism, prevention & control)
- Hypoxia
(complications)
- Indoles
(adverse effects)
- Lung
(drug effects, metabolism, pathology)
- Male
- Natriuretic Agents
(metabolism, therapeutic use)
- Natriuretic Peptide, C-Type
(metabolism, therapeutic use)
- Protein Kinase Inhibitors
(adverse effects)
- Pyrroles
(adverse effects)
- Rats
- Rats, Sprague-Dawley
- Receptors, Vascular Endothelial Growth Factor
(antagonists & inhibitors)
|